---
figid: PMC8346982__ijms-22-08102-g003
figtitle: Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor
  Microenvironment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8346982
filename: ijms-22-08102-g003.jpg
figlink: /pmc/articles/PMC8346982/figure/ijms-22-08102-f003/
number: F3
caption: (A) CLU mediates clearance of misfolded proteins through the chaperone- and
  receptor-mediated extracellular protein degradation (CRED) pathway. CLU binds a
  misfolded protein and then interacts with the HS chains membrane PGs by electrostatic
  interactions (I); the CLU–client protein-receptor is endocytosed (II) and delivered
  to the lysosome (III) for intracellular degradation (IV). (B) Intracellular signaling
  pathways triggered by CLU after surface receptors binding. CLU inhibits the TAK1–
  NF-κB signaling axis triggered by inflammatory cytokines. CLU facilitates eHSP90
  binding to LRP1, enhancing the activation of ERK, AKT, and NF-κB and promoting EMT.
  Finally, CLU binds LRP2 and promotes cell survival through PI3K/AKT activation.
papertitle: Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor
  Microenvironment.
reftext: Marina Marozzi, et al. Int J Mol Sci. 2021 Aug;22(15):8102.
year: '2021'
doi: 10.3390/ijms22158102
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: extracellular matrix remodeling | inflammation | tumor microenvironment
  | matrix metalloproteases | hyaluronan | extracellular chaperones | clusterin
automl_pathway: 0.9476075
figid_alias: PMC8346982__F3
figtype: Figure
redirect_from: /figures/PMC8346982__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8346982__ijms-22-08102-g003.html
  '@type': Dataset
  description: (A) CLU mediates clearance of misfolded proteins through the chaperone-
    and receptor-mediated extracellular protein degradation (CRED) pathway. CLU binds
    a misfolded protein and then interacts with the HS chains membrane PGs by electrostatic
    interactions (I); the CLU–client protein-receptor is endocytosed (II) and delivered
    to the lysosome (III) for intracellular degradation (IV). (B) Intracellular signaling
    pathways triggered by CLU after surface receptors binding. CLU inhibits the TAK1–
    NF-κB signaling axis triggered by inflammatory cytokines. CLU facilitates eHSP90
    binding to LRP1, enhancing the activation of ERK, AKT, and NF-κB and promoting
    EMT. Finally, CLU binds LRP2 and promotes cell survival through PI3K/AKT activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - clu
  - ab
  - Tak1
  - IKKepsilon
  - key
  - IKKbeta
  - Dif
  - dl
  - Rel
  - egr
  - JIL-1
  - dpp
  - gbb
  - put
  - mav
  - Mmp1
  - LRP1
  - Erk7
  - rl
  - Akt
  - sna
  - slug
  - LpR2
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CLU
  - MAP3K7
  - NR2C2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - TNF
  - IL6
  - IL1B
  - TGFB1
  - TGFB2
  - TGFB3
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - C1D
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - SNAI1
  - SNAI2
  - ZEB1
  - ITK
  - SLC22A3
  - LRP2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
---
